Serdar Ünlü

777 total citations
31 papers, 663 citations indexed

About

Serdar Ünlü is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Serdar Ünlü has authored 31 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 8 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Serdar Ünlü's work include Synthesis and biological activity (19 papers), Synthesis and Reactions of Organic Compounds (15 papers) and Synthesis of heterocyclic compounds (11 papers). Serdar Ünlü is often cited by papers focused on Synthesis and biological activity (19 papers), Synthesis and Reactions of Organic Compounds (15 papers) and Synthesis of heterocyclic compounds (11 papers). Serdar Ünlü collaborates with scholars based in Türkiye, Spain and Japan. Serdar Ünlü's co-authors include Mustafa Şahin, Esra Küpeli̇, Erden Banoğlu, Deniz S. Doğruer, Erdem Yeşilada, Erdem Yeşilada, Shigeru Ito, Antonio Entrena, Francisco José da Silva Lédo and Sultan Nacak Baytaş and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Archives of Pharmacal Research.

In The Last Decade

Serdar Ünlü

31 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serdar Ünlü Türkiye 15 536 141 108 39 38 31 663
Farghaly A. Omar Egypt 16 460 0.9× 115 0.8× 213 2.0× 61 1.6× 25 0.7× 42 711
Ravinesh Mishra India 12 664 1.2× 75 0.5× 212 2.0× 87 2.2× 46 1.2× 32 885
Nilanchala Sahu India 5 374 0.7× 79 0.6× 133 1.2× 40 1.0× 36 0.9× 9 534
Zsuzsanna Rozmer Hungary 9 338 0.6× 114 0.8× 212 2.0× 27 0.7× 48 1.3× 20 540
Ali Almasirad Iran 14 594 1.1× 89 0.6× 182 1.7× 92 2.4× 28 0.7× 37 788
Shivkumar S. Jalde India 12 319 0.6× 102 0.7× 140 1.3× 42 1.1× 32 0.8× 13 546
Syed Muhammad Kashif Pakistan 14 454 0.8× 65 0.5× 135 1.3× 77 2.0× 25 0.7× 23 650
Waqas Jamil Pakistan 16 575 1.1× 78 0.6× 176 1.6× 98 2.5× 30 0.8× 29 753
S. Anbazhagan India 11 373 0.7× 101 0.7× 133 1.2× 65 1.7× 20 0.5× 38 619
H. S. Joshi India 16 579 1.1× 113 0.8× 91 0.8× 37 0.9× 22 0.6× 127 829

Countries citing papers authored by Serdar Ünlü

Since Specialization
Citations

This map shows the geographic impact of Serdar Ünlü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdar Ünlü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdar Ünlü more than expected).

Fields of papers citing papers by Serdar Ünlü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdar Ünlü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdar Ünlü. The network helps show where Serdar Ünlü may publish in the future.

Co-authorship network of co-authors of Serdar Ünlü

This figure shows the co-authorship network connecting the top 25 collaborators of Serdar Ünlü. A scholar is included among the top collaborators of Serdar Ünlü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdar Ünlü. Serdar Ünlü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taçoy, Gülten, Atiye Çengel, Yakup Alsancak, Serdar Ünlü, & Sedat Türkoğlu. (2015). Combinaton Therapy in Pulmonary Arterial Hypertension: Single Center Long-term Experience. West Indian Medical Journal. 65(1). 46–51. 1 indexed citations
2.
Gülcan, Hayrettin Ozan, et al.. (2015). Marginally Designed New Profen Analogues Have the Potential to Inhibit Cyclooxygenase Enzymes. Archiv der Pharmazie. 348(1). 55–61. 3 indexed citations
3.
Gülcan, Hayrettin Ozan, et al.. (2014). Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors. Bioorganic & Medicinal Chemistry. 22(19). 5141–5154. 33 indexed citations
4.
Baytaş, Sultan Nacak, et al.. (2013). Novel 1,3-diarylpyrazole acrylamides: synthesis, antiplatelet activity screening, and in silico evaluation studies. Medicinal Chemistry Research. 22(12). 5922–5933. 6 indexed citations
5.
Eren, Gökçen, Serdar Ünlü, Luis Labeaga, et al.. (2010). Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 18(17). 6367–6376. 89 indexed citations
6.
Ünlü, Serdar, Erden Banoğlu, Antonio Entrena, et al.. (2008). Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. European Journal of Medicinal Chemistry. 44(5). 1830–1837. 27 indexed citations
7.
Ünlü, Serdar, et al.. (2007). Synthesis, characterization and preliminary screening of regioisomeric 1-(3-pyridazinyl)-3-arylpyrazole and 1-(3-pyridazinyl)-5-arylpyrazole derivatives towards cyclooxygenase inhibition. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(3). 351–361. 11 indexed citations
8.
Köksel, Oğuz, Ali Özdülger, Lülüfer Tamer, et al.. (2005). Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats. Pulmonary Pharmacology & Therapeutics. 19(2). 90–95. 46 indexed citations
10.
Aydın, Abdullah, Tíjen Önkol, Mehmet Akkurt, Orhan Büyükgüngör, & Serdar Ünlü. (2004). 5-Chloro-6-(2-fluorobenzoyl)-1,3-benzoxazol-2(3H)-one. Acta Crystallographica Section E Structure Reports Online. 60(2). o244–o245. 1 indexed citations
11.
Gülcan, Hayrettin Ozan, Serdar Ünlü, Erden Banoğlu, et al.. (2003). Synthesis of New 4-(5-Chloro-2-oxo-3H-benzoxazol-3-yl)butanamide Derivatives and Their Analgesic and Anti-Inflammatory Properties. TURKISH JOURNAL OF CHEMISTRY. 27(4). 467–476. 16 indexed citations
12.
Ünlü, Serdar, Sultan Nacak Baytaş, Esra Küpeli̇, & Erdem Yeşilada. (2003). Studies on Novel 7‐Acyl‐5‐chloro‐2‐oxo‐3H‐benzoxazole Derivatives as Potential Analgesic and Anti‐Inflammatory Agents. Archiv der Pharmazie. 336(6-7). 310–321. 39 indexed citations
14.
Gülcan, Hayrettin Ozan, Esra Küpeli̇, Serdar Ünlü, Erdem Yeşilada, & Mustafa Şahin. (2003). 4‐(5‐Chloro‐2(3H)‐benzoxazolon‐3‐yl) Butanoic Acid Derivatives: Synthesis, Antinociceptive and Anti‐inflammatory Properties. Archiv der Pharmazie. 336(10). 477–482. 21 indexed citations
15.
17.
Doğruer, Deniz S., et al.. (2000). Studies on Some 3(2H)-Pyridazinone Derivatives with Antinociceptive Activity. Archiv der Pharmazie. 333(4). 79–86. 47 indexed citations
18.
Şafak, Cihat, et al.. (1994). 2-(6-Acyl-2-benzoxazolinone-3-yl)acetamide and acetonitrile derivatives with analgesic activities.. PubMed. 49(1). 63–4. 5 indexed citations
19.
Palaska, Erhan, et al.. (1993). 1-(3-Methyl-2-benzoxazolinone-6-yl)-2-(4-substituted piperazine-1-yl)ethanones and ethanols: analgesic and antiinflammatory activities. European Journal of Medicinal Chemistry. 28(12). 963–967. 14 indexed citations
20.
Ünlü, Serdar, et al.. (1989). Analgesic Activity of Some 3‐(Arylpiperidinomethyl)‐2‐benzoxazolinone Derivatives. Archiv der Pharmazie. 322(2). 75–77. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026